Project Details
Description
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of a Single Infusion of Bezlotoxumab
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/17 → 4/30/22 |
Funding
- MERCK AND CO INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.